Intensity Therapeutics Inc

+0.01 (+0.27%)
4:03:34 PM EDT: $3.68 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Intensity Therapeutics Inc Stock, NASDAQ:INTS

61 Wilton Road, 3rd floor, Westport, Connecticut 06880
United States of America
Phone: +
Number of Employees: 16


Intensity Therapeutics, Inc. engages in the operation a biotechnology company which develops novel immune-based therapeutic products for cancer treatment. Its product INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Westport, CT.